Newsmakers

Stephen Parodi, MD, shared his insights on the field of epidemiology and what makes it personally fulfilling for him in U.S. News & World Report.

In an interview with the New York Times, Rebecca Boxer, MD, discusses how a new clinical trial will serve a population greatly in need of targeted COVID-19 treatments.

In an interview with Becker’s Healthcare founder and publisher Scott Becker, Imelda Dacones, MD, president and CEO of Northwest Permanente, reflects on her journey as a physician leader.

SCPMG ophthalmologist and researcher Bobeck Modjtahedi, MD, shared results of a study presented at the 2020 virtual meeting of American Society of Retina Specialists.

David Grossman, MD, of Washington Permanente Medical Group, and Eric Larson, MD, of Kaiser Permanente Washington Health Research Institute, published a peer-reviewed viewpoint in JAMA about the potentially powerful implications of population genomics for the future of health care.

In an opinion piece for MedPage Today, Nancy Gin, MD, chief quality officer for The Permanente Federation, describes how COVID-19 has given health care a much-needed transformational jolt.

Southern California Permanente Medical Group research scientist Deborah Cohen, MD, shares with The Washington Post key steps people can take to boost their nutrition.

The Permanente Federation Chief Information Officer Ed Lee, MD, tells Politico that Permanente physicians need to adjust telehealth use to the COVID-19 pandemic’s ebbs and surges.

A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.